1. Home
  2. AMRX vs HURN Comparison

AMRX vs HURN Comparison

Compare AMRX & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • HURN
  • Stock Information
  • Founded
  • AMRX 2002
  • HURN 2002
  • Country
  • AMRX United States
  • HURN United States
  • Employees
  • AMRX N/A
  • HURN N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • HURN Professional Services
  • Sector
  • AMRX Health Care
  • HURN Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • HURN Nasdaq
  • Market Cap
  • AMRX 2.5B
  • HURN 2.3B
  • IPO Year
  • AMRX N/A
  • HURN 2004
  • Fundamental
  • Price
  • AMRX $8.07
  • HURN $132.84
  • Analyst Decision
  • AMRX Strong Buy
  • HURN Strong Buy
  • Analyst Count
  • AMRX 4
  • HURN 4
  • Target Price
  • AMRX $11.50
  • HURN $170.75
  • AVG Volume (30 Days)
  • AMRX 1.5M
  • HURN 165.7K
  • Earning Date
  • AMRX 08-05-2025
  • HURN 07-31-2025
  • Dividend Yield
  • AMRX N/A
  • HURN N/A
  • EPS Growth
  • AMRX N/A
  • HURN 92.74
  • EPS
  • AMRX N/A
  • HURN 6.67
  • Revenue
  • AMRX $2,830,186,000.00
  • HURN $1,525,814,000.00
  • Revenue This Year
  • AMRX $9.95
  • HURN $11.50
  • Revenue Next Year
  • AMRX $8.14
  • HURN $7.48
  • P/E Ratio
  • AMRX N/A
  • HURN $19.92
  • Revenue Growth
  • AMRX 13.42
  • HURN 8.98
  • 52 Week Low
  • AMRX $6.50
  • HURN $101.73
  • 52 Week High
  • AMRX $9.48
  • HURN $155.00
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 49.92
  • HURN 43.84
  • Support Level
  • AMRX $7.79
  • HURN $129.50
  • Resistance Level
  • AMRX $8.48
  • HURN $134.24
  • Average True Range (ATR)
  • AMRX 0.20
  • HURN 2.71
  • MACD
  • AMRX -0.06
  • HURN -0.10
  • Stochastic Oscillator
  • AMRX 37.84
  • HURN 31.10

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HURN Huron Consulting Group Inc.

Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.

Share on Social Networks: